Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Maintains Equal-Weight on Zymeworks BC, Raises Price Target to $9

Barclays analyst Gena Wang maintains Zymeworks BC (NYSE:ZYME) with a Equal-Weight and raises the price target from $7 to $9.
byBenzinga Newsdesk
December 22, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Barclays analyst Gena Wang maintains Zymeworks BC (NYSE:ZYME) with a Equal-Weight and raises the price target from $7 to $9.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts